| abstract |
The present invention describes the compounds of formula I, in which A, m and R1 have the meanings defined herein, are inhibitors of hepatitis C virus (HCV) polymerase. Compositions and methods for the treatment of HCV-mediated diseases and for inhibiting hepatitis replication are also described. Processes for obtaining the compounds and intermediate synthetic compounds used in the process are also described. (See Formula I). |